Comparing between Hydroxyurea and Non-Hydroxyurea Anti-inflammatory Cytokines in Sickle Cell Anemia Saudi Patients

被引:0
|
作者
Tarbiah, Nesrin, I [1 ]
Alamri, Reema S. [1 ]
Alkhattabi, Nuha A. [1 ]
Alhemadi, Maryam M. [1 ]
Almutairi, Huda S. [1 ]
Alzahri, Reem Y. [2 ]
Hussain, Hend [3 ]
机构
[1] King Abdulaziz Univ, Dept Biochem, Jeddah, Saudi Arabia
[2] Jeddah Univ, Dept Biol, Jeddah, Saudi Arabia
[3] King Abdulaziz Univ, Dept Hematol, Jeddah, Saudi Arabia
关键词
Anti-inflammatory cytokines; Hydroxyurea; Inflammation; Sickle cell disease; DISEASE PATIENTS; IL-37;
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Sickle Cell Anemia (SCA) is a hemolytic deficiency that is typified by strangely formed (sickles) red blood cells that are expelled from circulation at expanded rates, leading to anemia. It is caused by inheritance of hemoglobin (Hb) that has mutated, which compared to adult normal Hb, contains a single amino acid substitution, where at the sixth residue valine substitutes glutamic acid in the Hb tetramer in both of the two B chains. For SCA patients, chronic inflammatory conditions are linked to high levels of inflammation markers, including cytokines and adhesion molecules. Cytokines are a group of small proteins that are essential in cell signaling. The immuno regulatory molecules known as anti-inflammatory cytokines control the response of pro inflammatory and have gained attention recently as anti-inflammatory mediator in SCA patients. The most interesting anti-inflammatory cytokines are IL-10, IL-4, IL-27, and IL-37. This a case-control study aimed to measure the concentrations of the anti-inflammatory cytokines in 3 groups, SCA patients without the use of any medication, SCA patients under Hydroxy Urea therapy (SCAHU), and healthy people (male and female) in the general Saudi population, using a total of 78 chosen subjects. Using ELISA kits, cytokine levels were measured in the plasma of the patients. The results of the study indicated that anti-inflammatory cytokines were elevated in SCA and SCAHU patients when compared to the control (P=0.001), and there were no significant differences between SCA and SCAHU patients. The anti-inflammatory cytokines, including IL-27 and IL-37, that were detected for the first time in SCA patients in KSA in this research, have a role in keeping patients in a steady-state and reducing inflammation, therefore more research to understand the roles of these cytokines in SCA pathology of is essential to allow the development of effective therapies to treat this disease.
引用
收藏
页码:39 / 44
页数:6
相关论文
共 50 条
  • [41] HYDROXYUREA - EFFECTS ON HEMOGLOBIN-F PRODUCTION IN PATIENTS WITH SICKLE-CELL-ANEMIA
    CHARACHE, S
    DOVER, GJ
    MOORE, RD
    ECKERT, S
    BALLAS, SK
    KOSHY, M
    MILNER, PFA
    ORRINGER, EP
    PHILLIPS, G
    PLATT, OS
    THOMAS, GH
    BLOOD, 1992, 79 (10) : 2555 - 2565
  • [42] ADHERENCE TO HYDROXYUREA THERAPY IN SICKLE CELL ANEMIA PATIENTS DURING THE COVID 19 PANDEMIC
    Bresler, Michele
    Kasangottu, Anoosha
    Raybagkar, Deepti
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S32 - S32
  • [43] The Association Between Hydroxyurea Treatment and Pain Intensity, Analgesic Use, and Utilization in Ambulatory Sickle Cell Anemia Patients
    Smith, Wally R.
    Ballas, Samir K.
    McCarthy, William F.
    Bauserman, Robert L.
    Swerdlow, Paul S.
    Steinberg, Martin H.
    Waclawiw, Myron A.
    PAIN MEDICINE, 2011, 12 (05) : 697 - 705
  • [44] Patterns of prescribing hydroxyurea for sickle cell disease patients from a central hospital, Saudi Arabia
    Elghazaly, Assem A.
    Aljatham, Add A.
    Khan, Abdulaziz M.
    Elneil, Rasha M.
    Jafar, S. Zubair S.
    Elwishy, Salah A.
    Ahmed, Omsalma E.
    Bughnah, Aamer M.
    Ibrahim, Mamoun H.
    HEMATOLOGY REPORTS, 2019, 11 (01) : 9 - 11
  • [45] Rheological properties of sickle erythrocytes in patients with sickle-cell anemia: The effect of hydroxyurea, fetal hemoglobin, and α-thalassemia
    Ballas, Samir K.
    Connes, Philippe
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 101 (06) : 798 - 803
  • [46] Microarray Analysis of Erythroid Gene Expression In Sickle Cell Anemia Patients Treated with Hydroxyurea.
    Flanagan, Jonathan Michael
    Steward, Shirley
    Howard, Thad A.
    Mortier, Nicole A.
    Kimble, Amy C.
    Aygun, Banu
    Hankins, Jane S.
    Neale, Geoffrey A.
    Ware, Russell E.
    BLOOD, 2010, 116 (21) : 682 - 682
  • [47] Lower Transcranial Doppler Flow Velocities in Sickle Cell Anemia Patients on Hydroxyurea: Myth or Fact
    Sawsan M. Moeen
    Ahmad F. Thabet
    Hosam A. Hasan
    Medhat A. Saleh
    Indian Journal of Hematology and Blood Transfusion, 2018, 34 : 97 - 103
  • [48] Temporary interruption of hydroxyurea as a method for achieving progenitor cell mobilization in patients with sickle cell anemia.
    Siritanaratkul, N
    Heimfeld, S
    Skarpidi, E
    Blau, CA
    BLOOD, 1998, 92 (10) : 160A - 160A
  • [49] STIMULATION OF F-CELL PRODUCTION IN PATIENTS WITH SICKLE-CELL-ANEMIA TREATED WITH CYTARABINE OR HYDROXYUREA
    VEITH, R
    GALANELLO, R
    PAPAYANNOPOULOU, T
    STAMATOYANNOPOULOS, G
    NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (25): : 1571 - 1575
  • [50] Effect of hydroxyurea therapy on intravascular hemolysis and endothelial dysfunction markers in sickle cell anemia patients
    Chenou, Francine
    Hounkpe, Bidossessi Wilfried
    Domingos, Igor de Farias
    Tonasse, Wouitchekpo Vincent
    Chaves Batista, Thais Helena
    Santana, Rodrigo Marcionilo
    Arcanjo, Gabriela da Silva
    Alagbe, Adekunle Emmanuel
    Araujo, Aderson da Silva
    Lucena-Araujo, Antonio Roberto
    Cavalcanti Bezerra, Marcos Andre
    Costa, Fernando Ferreira
    Sonati, Maria de Fatima
    De Paula, Erich Vinicius
    Nunes dos Santos, Magnun Nueldo
    ANNALS OF HEMATOLOGY, 2021, 100 (11) : 2669 - 2676